Navigation Links
Array Announces Global Phase 3 Trial Evaluating MEK162 In Patients With Low-Grade Serous Ovarian Cancer
Date:5/6/2013

domized Phase 3 trial will evaluate MEK162 against physician's choice of standard chemotherapy treatments in 300 patients with recurrent or persistent LGSOC following at least one prior platinum-based chemotherapy regimen and no more than three lines of prior chemotherapy regimens. The primary endpoint is progression-free survival, and the key secondary endpoint is overall survival.

"This trial is yet another indication of our continued progress towards our products being commercialized," said Ron Squarer, Chief Executive Officer, Array BioPharma.  "MEK162 is planned to be in three pivotal trials, which along with other ongoing and planned studies, is expected to position this drug to demonstrate its broad activity across a variety of tumor types."

As part of the agreement with Novartis, Array is entitled to royalties on worldwide sales, with royalties on U.S. sales at a higher level. Array is co-developing MEK162 with Novartis and retains an option to co-detail the product in the United States.

About Low-grade Serous Ovarian Cancer
Ovarian cancer is the tenth most common cancer among women, the fifth leading cause of cancer-related death among women, and is the deadliest of gynecologic cancers.  Serous ovarian cancer represents the largest group of ovarian cancer and is considered to consist of two main subtypes: low-grade and high-grade.  LGSOC represents up to 10 percent of ovarian cancer diagnoses, and it is estimated that over 10,000 women are living with the disease in the United States and Europe.  Patients with LGSOC are generally diagnosed at a younger age and live longer, but have a lower response rate to conventional chemotherapy compared to patients with high-grade serous ovarian cancer.  Management for advanced disease involves surgery and multiple anti-cancer regimens.  Less than 4 percent of patients with recurrent LGSOC respond to chemotherapy
'/>"/>

SOURCE Array BioPharma
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Global Array Instrument Market is Expected to Reach USD 3.2 Billion Globally in 2017: Transparency Market Research
2. Array BioPharma Reports Financial Results For The First Quarter Of Fiscal 2013
3. Array BioPharma To Present Clinical Data On ARRY-797 At The 2012 American College Of Rheumatology Annual Meeting
4. Array BioPharma Announces Proposed Public Offering Of Common Stock
5. Array BioPharma Announces Pricing Of Public Offering Of Common Stock
6. Array BioPharma To Present At The Piper Jaffray Annual Healthcare Conference
7. InternetArray Collaborates with Health Sciences Group to Fund Medical Marijuana Social Media/Mobile Apps Development
8. Array BioPharma To Present At The Leerink Swann Global Healthcare Conference
9. Zacks Bull and Bear of the Day Highlights: Fortune Brands Home & Security, Wal-Mart Stores, Regeneron Pharmaceuticals, Bayer and Array Biopharma
10. Array BioPharma To Present At The Cowen Annual Health Care Conference
11. Array BioPharma Names Michael N. Needle, M.D. As Chief Medical Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... FORT WORTH, Texas , Jan. 15, 2014  Humberto ... in Dermatology Achievement Award" from the Journal of ... Dermatology Aesthetic & Clinical Conference (ODAC). The event is January ... Florida . The ...
(Date:1/15/2014)... 2014  Manufacturers, suppliers and distributors of innovative medical-related ... their most important business assets, intellectual property (IP). ... Because of the highly-competitive nature of the ... the most litigious industry sectors of cases involving ...
(Date:1/15/2014)... Tegra Medical is very pleased to announce the appointment ... Chief Executive Officer.  Mark was promoted from his current role ... company,s four facilities in Massachusetts , ... Tegra Medical in 2012 with 20+ years of broad-based operations, ...
Breaking Medicine Technology:Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 2Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 3Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 4Intellectual Property Insurance for Medical-related Products and Services 2Tegra Medical Appoints New Chief Executive Officer 2Tegra Medical Appoints New Chief Executive Officer 3
... 15, 2011 Vantage Health (OTC:BB – ticker symbol ... tender submissions (the "tender", "tenders") have been accepted by ... Dar es Salaam. The tenders will not be adjudicated, ... any award in this respect, until December 02, 2011. ...
... VIEW, Calif., Sept. 15, 2011 VIVUS, Inc. (NASDAQ: ... it has reached agreement with officials of the Endocrine and ... plan that allows for an early resubmission of the QNEXA ... plan allows VIVUS to seek approval for an initial indication ...
Cached Medicine Technology:Vantage Health Submits Tender Documents for Tanzania Medical Stores Department and University of Dar es Salaam Procurement Tenders 2Vantage Health Submits Tender Documents for Tanzania Medical Stores Department and University of Dar es Salaam Procurement Tenders 3VIVUS Provides Regulatory Update on QNEXA 2VIVUS Provides Regulatory Update on QNEXA 3VIVUS Provides Regulatory Update on QNEXA 4
(Date:7/9/2014)... , , , , , ... , , , , ... the weapon was an SA80 assault rifle and the microphone is 50m downrange from the firer and approximately 30cm from the bullet... , ... , , , , ... , , , , , ...
(Date:7/9/2014)... allergic diseases has risen dramatically in Western societies. One ... to microorganisms and have fewer infections than previous generations, ... study by researchers at Sahlgrenska Academy, University of Gothenburg, ... maturation of the immune system in relation to allergic ... of the Vstra Gtaland Region, half of them on ...
(Date:7/8/2014)... longevity and cardiovascular health as other healthy mature individuals, ... American Journal of Transplantation . The findings may provide ... transplant professionals caring for them. , Over the past ... years and older has become more common. Given the ... the removal of a kidney could make older donors ...
(Date:7/8/2014)... The Department of Defense,s Defense Advanced Research Projects ... up to $2.5 million to develop an implantable ... stimulate neurons within the brain to help restore ... research builds on the understanding that memory is ... of the brain encode information, store it and ...
(Date:7/8/2014)... were found to be three times higher when auditors ... no auditors present, according to a study in a ... titled, "Quantification of the Hawthorne effect in hand hygiene ... cohort study," published today on-line in the BMJ ... Jocelyn Srigley, who did the study as part of ...
Breaking Medicine News(10 mins):Health News:Fit for the frontline? New study identifies the hearing requirements of British soldiers 2Health News:Fit for the frontline? New study identifies the hearing requirements of British soldiers 3Health News:Fit for the frontline? New study identifies the hearing requirements of British soldiers 4Health News:Fit for the frontline? New study identifies the hearing requirements of British soldiers 5Health News:Fit for the frontline? New study identifies the hearing requirements of British soldiers 6Health News:Fit for the frontline? New study identifies the hearing requirements of British soldiers 7Health News:Study finds kidney donation safe for healthy older adults 2Health News:DARPA selects Lawrence Livermore to develop world's first neural device to restore memory 2Health News:DARPA selects Lawrence Livermore to develop world's first neural device to restore memory 3Health News:Health-care worker hand hygiene rates increase three-fold when auditors visible 2Health News:Health-care worker hand hygiene rates increase three-fold when auditors visible 3
... , Dec. 24th Vote Looming, AARP Calls on Senators to ... of Idaho,s Health Care Woes , BOISE, Idaho, Dec. 23 ... families this holiday season, rising health care costs are an issue ... woes grow increasingly worse, AARP is calling on Senators Mike Crapo ...
... in study lost bone mass within two years , WEDNESDAY, ... who received the "birth control shot" -- also known as ... percent of their bone mineral density in the hip and ... who had never given birth and who didn,t consume much ...
... rolls around and you,re deciding whether to have another glass ... of the future. A pair of Kansas State University ... long term are more likely to make positive decisions about ... eat, or their decision to wear sunscreen. "If you ...
... , , LOUISVILLE, Ky., Dec. 23 ... companies today called on Congress to drop language that would ... food and beverage products prior to the point of sale, ... The requirement is included in both the House and ...
... , , , NEW YORK, Dec. ... by the Center for Disease Control and Prevention (CDC) and ... that approximately 673,000 children aged 3-21 have been diagnosed with ... that children with autism need increased access to evidence-based interventions, ...
... mushroom commonly used in Chinese medicine, could be made more ... works. The research is funded by the Biotechnology and Biological ... of Nottingham. In research to be published in the ... of The University of Nottingham and her team have investigated ...
Cached Medicine News:Health News:AARP Urges Idaho Senators Not to be the Grinches That Stole Health Care Reform 2Health News:Contraceptive Depo-Provera May Weaken Bones 2Health News:K-State psychologists show that future-minded people make better decisions for their health 2Health News:K-State psychologists show that future-minded people make better decisions for their health 3Health News:Vend Marketing Institute Calls on Congress to Modify Calorie Disclosure Requirement: Supports Existing Disclosure Which Is More Complete and Effective 2Health News:Vend Marketing Institute Calls on Congress to Modify Calorie Disclosure Requirement: Supports Existing Disclosure Which Is More Complete and Effective 3Health News:Autism Treatment Crisis: Insufficient Number of Providers to Meet Alarming Increase in Need 2Health News:Autism Treatment Crisis: Insufficient Number of Providers to Meet Alarming Increase in Need 3Health News:New insights into mushroom-derived drug promising for cancer treatment 2
... In addition to three conventional measurement modes ... also incorporates a new axial length measuring ... by calculating sonic velocity for conversion at ... length by calculating each tissues sonic velocity ...
... with graphic display and IOL power ... combination units include firmware module with ... II formulas. Audible tones increase in ... visual axis. Constant tone when alignment ...
... Artemis is the world's first very high ... 3D Arc-scanning technology, Artemis provides microscopic resolution ... cornea and anterior segments of the human ... (VHF) ultrasound eye scanner. In use, the ...
... The ISYSTEM-ABD ("I-cubed") is an exceptionally ... an analog oscilloscope (static deflection) display. ... resolution than low cost video monitors. ... syneresis, inflammatory cells, as well as ...
Medicine Products: